glp-1 intestinal paralysis lawyer in kentucky semaglutide gastric obstruction lawsuit gastrointestinal law office kentucky obstruction kentucky semaglutide gastrointestinal kentucky glp-1 gastrointestinal obstruction law – semaglutide gastric intestinal obstruction law

Because of its broader receptor activity, it may theoretically have more pronounced effects on reward and energy pathways, though human data on libido effects remain limited

January 7, 2026

In March 2025, Roche and Zealand Pharma launched an Up-to-$5.3B obesity collaboration to co-develop and co-commercialize Zealands petrelintide for overweight and obesity indications

Importantly, as there has been discussion in the media about possible adverse effects of the drugs on mental health, the group taking the drug had a lower incidence of schizophrenia, alcohol and drug use disorders, and less suicidal ideation

Watch for warning signs Its important when outside in the summer heat to know your body and be aware of its limits, especially when exercising

18 Given that Medicare Part D does cover GLP-1 drugs when theyre prescribed for something other than weight loss, and given that the list of conditions for which GLP-1 medications are approved has grown, its not surprising to see that total Medicare Part D spending on these drugs has ballooned in recent years